FDA Recall Terminated

ARCHITECT HBsAg Qualitative Assay, List Number 4P53 and ARCHITECT HBsAg Qualitative Confirmatory Assay, List Number 4P54 The ARCHITECT HBsAg Qualitative assay is a chemiluminescent microparticle immunoassay (CMIA) for the qualitative detection of hepatitis B surface antigen (HBsAg) in human adult and pediatric serum and plasma and neonate serum.

Recall: Z-0987-2013 · Initiated December 18, 2012

Recall

Recall Number
Z-0987-2013
Event Number
63946
Firm
Abbott Laboratories, Inc
FEI Number
1628664
Product Code
LOM
Status
Terminated
Root Cause
No Marketing Application
Initiated
December 18, 2012
Posted
March 25, 2013
Terminated
July 31, 2013
Address
1921 Hurd Dr, Irving, TX, 75038-4313

Description

ARCHITECT HBsAg Qualitative Assay, List Number 4P53 and ARCHITECT HBsAg Qualitative Confirmatory Assay, List Number 4P54 The ARCHITECT HBsAg Qualitative assay is a chemiluminescent microparticle immunoassay (CMIA) for the qualitative detection of hepatitis B surface antigen (HBsAg) in human adult and pediatric serum and plasma and neonate serum.

Reason

Abbott has identified that assay files for the ARCHITECT HBsAg Qualitative and HBsAg Qualitative Confirmatory assays (LNs 4P53 and 4P54) on the ARCHITECT i1000SR System were mistakenly made available on abbottdiagnostics.com in October 2012. Additionally, some i1000SR customers received notification through AbbottLink in November 2012 that assay files for LNs 4P53 and 4P54 were available. The AR

Action

The firm decided to correct the issue and and sent out Urgent Field Safety Notices to their customers dated 10/18/2012.

Distribution

Nationwide Distribution including AZ, CA, FL, GA, HI, LA, MA, MD, MO, NJ, NY, PA, RI, TN, TX, UT, and WA.

Quantity

12